Skip to main content

Toronto CBD Firm Taps Ex-Acting U.S. Attorney General Whitaker For New Legal Advisor Role

Toronto-based CBD company Alternate Health Corp has hired Matthew Whitaker, former acting U.S. Attorney General, and his law firm Graves Garrett to serve as outside counsel. Best known for his brief tenure as U.S. Acting Attorney General after President Trump’s firing of firebrand cannabis foe Jeff Sessions, Whitaker generated controversy for his alleged ties to Trump and his comments about the Robert Mueller probe of Russian interference into the 2016 U.S. presidential election. In February 2019, Whitaker left his position after serving for only three months.

His appointment comes at a critical moment for Alternate Health, which recently stated that it was pivoting away from marijuana to focus more on hemp-derived CBD. Commenting on the high-profile hire, Alternate Health President Dr. Robert Blaine noted in a public statement how Whitaker is coming on board during a key inflection point for his company, currently divesting its cannabis assets.

“The legal environment surrounding CBD is rapidly evolving and it is essential that Alternate Health stays at the forefront of new government and FDA regulations,” he said. “We believe his experience in government and the Department of Justice is a significant asset as we move forward.”

Whitaker, who also served as Chief of Staff to then Attorney General Sessions from September 2017 to November 2018, is looking forward to his new role as a key legal advisor to Alternate Health. “I think there is serious potential in the CBD industry,” he said in a statement, “and everyone at Alternate Health will work hard to be a leader in the industry.”

According to Alternate Health, Whitaker will “tackle key issues” for the company. Foremost among them is “an investigation into certain actions in Canada by a California-based competitor.” When not conducting portentous probes into the misdeeds of unnamed rival companies, Whitaker’s other duties will include coordinating legal matters and developing Alternate Health’s “legal strategy as the company expands into new markets.”

Whitaker bears the distinction of being the latest high-ranking Republican to take his knowledge and juridical prowess to the cannabis/CBD/hemp market. John Boehner, former Speaker of the House, has become a very vocal champion of the space, even sitting on the board of Acreage Holdings, a New York-based multistate cannabis operator.

Whitaker’s skills working (or haggling) with D.C. lawmakers may be put to good use in his new position. Said Howard Mann, Alternate Health CEO, in a statement: “His knowledge and experience open doors at many of the most important institutions concerning our industry. I am also impressed with his toughness and tenacity he developed as a prosecutor, enforcing state and federal laws, examining alleged legal violations and setting a standard of fairness and justice.”

In addition to his serving as Acting U.S. Attorney General, Whitaker has donned other hats in the legal realm. This includes working as the U.S. Attorney for the Southern District of Iowa. In addition to his affiliation with the Graves Garrett law firm, Whitaker is also the managing director for Axiom Strategies/Clout Public Affairs.

Original Article Source: https://www.forbes.com/sites/irisdorbian/2019/08/28/toronto-cbd-firm-taps-ex-acting-u-s-attorney-general-whitaker-for-new-legal-advisor-role/

Comments

Post a Comment

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...
Post a Comment
Read more

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...
Post a Comment
Read more

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...
Post a Comment
Read more